This inventor holds 2 USPTO granted patents. Top assignee: Animal Technology Institute. Active years: 2003-2008.
Location History:
- Taipei, TW (2003)
- Miaoli Hsien, TW (2008)
Company Filing History:
Years Active: 2003-2008
Title: Innovations in Xenotransplantation by Chun-Jean Lee
Introduction
Chun-Jean Lee is a prominent inventor based in Miaoli, Taiwan. He has made significant contributions to the field of xenotransplantation through his innovative research and inventions. With a total of 2 patents, Lee's work focuses on developing transgenic animals that can provide viable organs and tissues for human transplantation.
Latest Patents
Lee's latest patents include groundbreaking inventions that enhance the potential for xenotransplantation. The first patent, titled "Transgenic pigs carrying both hHO-1 and hDAF transgenes for xenotransplantation," describes a transgenic animal that carries two important transgenes. One encodes a human decay accelerating factor (hDAF), while the other encodes a human heme oxygenase-1 (hHO)-1. This invention is crucial for providing cells, tissues, or organs for xenotransplantation. The second patent, "Transgenic swine having HLA-D gene, swine cells thereof and xenografts therefrom," presents a transgenic swine that contains a transgene encoding a human HLA-DQ or HLA-DR protein. This invention also includes grafts derived from the transgenic swine, which are particularly useful for grafting into human recipients.
Career Highlights
Chun-Jean Lee is affiliated with the Animal Technology Institute, where he conducts his research and development. His work has positioned him as a key figure in the field of xenotransplantation, contributing to advancements that could potentially save countless lives.
Collaborations
Lee collaborates with notable colleagues, including Ching-Fu Tu and Chi-Kai Yang. Their combined expertise enhances the research efforts at the Animal Technology Institute, fostering innovation in the field.
Conclusion
Chun-Jean Lee's contributions to xenotransplantation through his innovative patents demonstrate his commitment to advancing medical science. His work has the potential to revolutionize organ transplantation and improve patient outcomes.